Shanghai Fosun Pharmaceutical (Group) Co., Ltd.
600196
Rang în acțiuni
#2197
Shanghai Fosun Pharmaceutical (Group) Co., Ltd. engages in the pharmaceutical... Shanghai Fosun Pharmaceutical (Group) Co., Ltd. engages in the pharmaceutical business in Mainland China and internationally. It operates through five segments: Pharmaceuticals, Medical Devices and Medical Diagnosis, Medical Services, Medical Distribution and Retail, and Others. The company is involved in the pharmaceutical manufacturing in the therapeutic areas of solid oncology, including tumors and hematologic malignancies, as well as immune-inflammatory disorders, metabolism and digestive systems, anti-infection, central nervous system, cardiovascular system, and APIs and intermediates. It also offers mRNA vaccines; medical aesthetic devices, such as medical aesthetic capital equipment, aesthetic dentistry, injectables, and personal care business units; mechanical ventilation devices under the Breas brand; and mobile pre-hospital care; professional in-hospital surgery and covers medical devices; and high-end surgical robots and medical consumables. In addition, the company provides diagnostics solutions comprising biochemical diagnostics, immune diagnostics, molecular diagnostics, microbiological diagnostics, pathological diagnostics, and chronic care management; and healthcare services, specialized medical treatment, online and offline medical services, and insurance services. Further, it engages in the operation of hospitals; and distribution and retail of healthcare products. Shanghai Fosun Pharmaceutical (Group) Co., Ltd. was founded in 1994 and is based in Shanghai, China.
Preț acțiune
$3.40
Capitalizare de piață
$9.07B
Schimbare (1 zi)
-1.61%
Schimbare (1 an)
-16.08%
Țară
CN
Tranzacționează Shanghai Fosun Pharmaceutical (Group) Co., Ltd. (600196)
Categorie
Healthcare
Marja operațională pentru Shanghai Fosun Pharmaceutical (Group) Co., Ltd. (600196)
Marja operațională la 2026 TTM: 0.00%
Conform celor mai recente rapoarte financiare și prețului acțiunilor Shanghai Fosun Pharmaceutical (Group) Co., Ltd., marja operațională curentă (TTM) este 0.00%. La finalul anului 2026, compania avea o marjă operațională de 0.00%.
Istoricul marjei operaționale pentru Shanghai Fosun Pharmaceutical (Group) Co., Ltd. din 2001 până în 2026
Marja operațională la sfârșitul fiecărui an
| An | Marja Operațională | Schimbă |
|---|---|---|
| 2025 | 6.08% | -41.20% |
| 2024 | 10.34% | 29.41% |
| 2023 | 7.99% | -24.55% |
| 2022 | 10.59% | -34.47% |
| 2021 | 16.16% | 3.72% |
| 2020 | 15.58% | -0.89% |
| 2019 | 15.72% | 10.78% |
| 2018 | 14.19% | -35.47% |
| 2017 | 21.99% | -5.22% |
| 2016 | 23.20% | -11.28% |
| 2015 | 26.15% | 31.34% |
| 2014 | 19.91% | 84.69% |
| 2013 | 10.78% | 33.25% |
| 2012 | 8.09% | -66.80% |
| 2011 | 24.37% | -2.68% |
| 2010 | 25.04% | 422.76% |
| 2009 | 4.79% | 29.81% |
| 2008 | 3.69% | -81.50% |
| 2007 | 19.95% | 142.11% |
| 2006 | 8.24% | 4.97% |
| 2005 | 7.85% | 64.92% |
| 2004 | 4.76% | -68.41% |
| 2003 | 15.07% | -7.72% |
| 2002 | 16.33% | -17.48% |
| 2001 | 19.79% | 0.00% |
Marja operațională pentru companii similare sau concurente
| Companie | Marja Operațională | Diferență în marja operațională | Țara |
|---|---|---|---|
| 0.00% | - |
DE
|
|
| 0.00% | - |
DE
|
|
| 0.00% | - |
JP
|
|
| 0.00% | - |
CH
|
|
| 22.93% | - |
IN
|
Ce este marja operațională a unei companii?
Marja operațională este un indicator esențial pentru evaluarea profitabilității unei companii. Marjele operaționale mai mari sunt de obicei mai bune, deoarece arată că o companie poate vinde produsele sau serviciile sale la prețuri mult mai mari decât costurile de producție. Marja operațională se calculează împărțind profitul companiei la venitul său.